Cargando…
Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders
Lysosomal storage diseases (LSDs) are a group of rare, life-threatening genetic disorders, usually caused by a dysfunction in one of the many enzymes responsible for intralysosomal digestion. Even though no cure is available for any LSD, a few treatment strategies do exist. Traditionally, efforts ha...
Autores principales: | Coutinho, Maria Francisca, Santos, Juliana Inês, Alves, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964441/ https://www.ncbi.nlm.nih.gov/pubmed/27384562 http://dx.doi.org/10.3390/ijms17071065 |
Ejemplares similares
-
Coutinho et al. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. Int. J. Mol. Sci. 2016, 17, 1065
por: Coutinho, Maria Francisca, et al.
Publicado: (2017) -
Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders
por: Coutinho, Maria Francisca, et al.
Publicado: (2016) -
Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example
por: Santos, Juliana Inês, et al.
Publicado: (2022) -
Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach
por: Coutinho, Maria Francisca, et al.
Publicado: (2020) -
Glycosaminoglycan Storage Disorders: A Review
por: Coutinho, Maria Francisca, et al.
Publicado: (2012)